Zeuss Tirzepatide Review: Cost, a LegitScript Seal the ranking Missed & Honest Verdict (2026)

Zeuss has a genuine LegitScript seal (#9177344) served from LegitScript's own CDN — this review found the certification live on the homepage, even though it wasn't captured in the ranking's original research. Every fact here comes from the company's own published program plus this review's own direct verification.

A LegitScript seal this review found, that the ranking missed

This review's direct check of Zeuss's homepage found a genuine LegitScript badge (seal #9177344) linking to `static.legitscript.com`, confirming real certification — an update on the original research, which had noted no LegitScript mention. Sites do add or update accreditation between research passes, and this is a positive update worth flagging directly.

What Zeuss is

Zeuss is a multi-vertical telehealth platform, offering compounded semaglutide and tirzepatide for weight loss alongside TRT, HRT, skin, and hair services. It uses a one-time-purchase model with no subscription — genuinely rare among DTC GLP-1 providers — and names both 503A and 503B compounding pathways, uncommon transparency.

What Zeuss costs

$175/month for tirzepatide, with bundled pricing covering provider review, medication, and cold-chain shipping — no hidden fees. A full refund is offered if a physician can't prescribe.

The brand-vs-compounded question

Zeuss dispenses compounded semaglutide and tirzepatide, and publishes the FDA compounded-medication disclaimer directly. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Zeuss's real strengths: a genuinely verified LegitScript seal, this check, plus a one-time-purchase model with no subscription lock-in, named 503A/503B pathways, bundled no-hidden-fee pricing, and a full refund if a physician can't prescribe. The trade-offs is the specific 503A pharmacy partner isn't named beyond a generic "state-licensed" framing, no named medical director or physician leadership, the full states-served list isn't disclosed, and the corporate legal entity isn't disclosed. As with any GLP-1 program, confirm your state's eligibility directly before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Zeuss's genuinely verified LegitScript seal — found live by this review — and its rare one-time-purchase, no-subscription model are real strengths. For a provider with a similarly verified seal and a named pharmacy partner, compare it against Vitara RX or VyraRX. See our best tirzepatide providers ranking for the full field.